Background The pathogenesis of pityriasis rubra pilaris (PRP) is not completely understood,
but interleukin (IL)‐17 has been shown to play a critical role. There are no reliable …

Pityriasis rubra pilaris (PRP) is a rare papulosquamous reaction pattern with a significant
impact on quality of life. Type I PRP is the most common PRP variant, presenting as …

Importance Pityriasis rubra pilaris is a rare and disabling cutaneous disease that is
frequently recalcitrant to conventional therapies and appears to involve interleukin (IL)-17 …

Pityriasis rubra pilaris (PRP) is a rare, papulosquamous, inflammatory skin disease. PRP
represents a therapeutic challenge. The rarity of this disease and its possible spontaneous …

Pityriasis rubra pilaris (PRP) is a rare, severe inflammatory skin disease associated with
high morbidity and debilitating effects on QOL (Eastham et al., 2019; Ross et al., 2016) …

Pityriasis rubra pilaris (PRP) is a papulosquamous disorder of unknown etiology. Most cases
are sporadic, but there are also familial forms caused by mutations in the CARD14 gene. 1 …

The patient had a history of chronic inflammatory bowel disease, thus excluding anti-
interleukin (IL)-17 therapy and he has also developed a needle phobia, thus excluding …

There is increasing evidence of adverse events associated with the use of COVID-19
vaccines. Here, we report a case of the SARS-CoV-2-vaccination-related onset of pityriasis …

Abstract Dear Editor, Pityriasis rubra pilaris (PRP) is a rare inflammatory dermatosis
characterized by keratotic follicular papules coalescing into scaly red-orange plaques. The …

Objective: To describe the published efficacy and adverse event rates associated with
existing biologics for the treatment of pityriasis rubra pilaris (PRP). Data Sources: A literature …